China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on establishing precise ICU antibacterial targets for cefotaxime/avibactam aimed at improving clinical outcomes and preventing resistance in the body'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135733
Registration Time: 2026/11/02
Type: Observational study
Primary Sponsor: Tongde Hospital Of Zhejiang Province
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343193
Published by HT Digital Content Services with permission from Health Daily Digest....